AI assistant
Sending…
BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2012
Mar 19, 2012
31868_dirs_2012-03-19_dd6e9f76-0973-4b78-a58d-3cce1a53d3fd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2012-03-15
Reporting Person: STAAB THOMAS R II (Senior Vice President and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-03-15 | Common Stock | A | 11989 | — | Acquired | 41286 | Direct |
| 2012-03-15 | Common Stock | F | 4162 | $5.23 | Disposed | 37124 | Direct |
Footnotes
F1: Restricted Stock Award-100% vested upon issue with a six month lock up for sale
F2: Shares withheld by BioCryst Pharmaceuticals, Inc. upon the vesting of restricted stock to satisfy the reporting person's tax withholding obligation.
More from BIOCRYST PHARMACEUTICALS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 24
Regulatory Filings
2026
Mar 20